OOEP
Oocyte-expressed protein homolog
Also known as: C6orf156, Em:AC019205.2, KHDC2, OOEP_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A6NGQ2
- Gene
- OOEP
- Ensembl
- ENSG00000203907
- Chromosome
- 6
- Canonical length
- 149 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
Predicted to enable RNA binding activity. Predicted to be involved in several processes, including cytoskeleton organization; positive regulation of double-strand break repair via homologous recombination; and positive regulation of meiotic nuclear division. Predicted to act upstream of or within several processes, including embryo implantation; in utero embryonic development; and protein phosphorylation. Located in cytoplasm and nucleus. Part of subcortical maternal complex. [provided by Alliance of Genome Resources, Apr 2025]
Canonical amino-acid sequenceUniProt
149 residues, UniProt reviewed canonical sequence.
>A6NGQ2|OOEP
1 MVDDAGAAES QRGKQTPAHS LEQLRRLPLP PPQIRIRPWW FPVQELRDPL VFYLEAWLAD
61 ELFGPDRAII PEMEWTSQAL LTVDIVDSGN LVEITVFGRP RVQNRVKSML LCLAWFHREH
121 RARAEKMKHL EKNLKAHASD PHSPQDPVALocalizationUniProt · AlphaFold · HPA
Whether an antibody against OOEP can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- testis: 13 nTPM
- salivary gland: 1.7 nTPM
- placenta: 1.3 nTPM
- pancreas: 0.9 nTPM
- skin: 0.9 nTPM
- blood vessel: 0.5 nTPM
Single-cell type
- enteric stem cells: 1,615 nCPM
- parietal cells: 1,528 nCPM
- gastric chief cells: 1,508 nCPM
- enteric transient amplifying cells: 1,262 nCPM
- paneth cells: 1,087 nCPM
- goblet cells: 973 nCPM
Immune cell
- gdT-cell: 0.7 nTPM
- memory B-cell: 0.5 nTPM
- eosinophil: 0.4 nTPM
- MAIT T-cell: 0.3 nTPM
- naive CD8 T-cell: 0.3 nTPM
- T-reg: 0.3 nTPM
Brain region
- cerebral cortex: 1.6 nTPM
- pons: 0.6 nTPM
- white matter: 0.6 nTPM
- medulla oblongata: 0.5 nTPM
- cerebellum: 0.4 nTPM
- hippocampal formation: 0.4 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.7
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.51
- DepMap mean gene effect
- -0.09
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin filament organization
- embryonic pattern specification
- establishment of spindle localization
- establishment or maintenance of apical/basal cell polarity
- positive regulation of double-strand break repair
- positive regulation of double-strand break repair via homologous recombination
- positive regulation of meiotic nuclear division
- protein storage
- regulation of cell division
- regulation of establishment of protein localization
- regulation of protein localization
- replication fork processing
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of OOEP in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OOEP as an antibody target. Whether an autoantibody or antibody against OOEP could matter depends on whether native OOEP is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OOEP is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OOEP as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...